For transgender people, starting gender-affirming hormone treatment in adolescence is linked to better mental health than waiting until adulthood, according to new research led by the Stanford University School of Medicine.
The study, which appeared online Jan. 12 in PLOS ONE, drew on data from the largest-ever survey of U.S. transgender adults, a group of more than 27,000 people who responded in 2015.
The new study found that transgender people who began hormone treatment in adolescence had fewer thoughts of suicide, were less likely to experience major mental health disorders and had fewer problems with substance abuse than those who started hormones in adulthood.
The study also documented better mental health among those who received hormones at any age than those who desired but never received the treatment.
“This study is particularly relevant now because many state legislatures are introducing bills that would outlaw this kind of care for transgender youth,” said Jack Turban, MD, a postdoctoral scholar in pediatric and adolescent psychiatry at Stanford Medicine.
